Navigation Links
Study compares standard against newer treatment in women whose breast cancer has spread
Date:12/7/2012

(Lebanon, NH, 12/7/12) Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival. This study was presented today by Peter A. Kaufman, M.D., during the 2012 CTRC-AACR San Antonio Breast Cancer Symposium.

"We didn't show a statistically significant superiority of eribulin over capecitabine, which was our goal," said Peter A. Kaufman, MD, associate professor of medicine at the Geisel School of Medicine at Dartmouth, and oncologist at Dartmouth-Hitchcock and Norris Cotton Cancer Center in Lebanon, N.H. "However, eribulin demonstrated a trend favoring an overall survival benefit, in comparison to capecitabine, which is a widely accepted and used standard therapy in this setting. Additionally, this is the first study demonstrating that eribulin is active earlier in the course of metastatic breast cancer," Kaufman said.

In 2010, the FDA approved eribulin for the treatment of patients with metastatic breast cancer who had previously received an anthracycline and a taxane and at least two cytotoxic chemotherapy treatment regimens for metastatic breast cancer. The FDA granted approval based on data showing a statistically significant improvement in overall survival compared with current treatments.

Kaufman and colleagues examined whether eribulin would be effective as an earlier-line treatment in women with metastatic breast cancer. They randomly assigned 1,102 patients to eribulin or capecitabine. Patients had all received prior anthracycline- and taxane-based therapy and received the study drug as the first, second or third line of therapy for metastatic disease.

The median overall survival for patients treated with eribulin was 15.9 months compared with 14.5 months for patients treated with
'/>"/>

Contact: Donna M. Dubuc
donna.m.dubuc@hitchcock.org
603-653-3615
Dartmouth-Hitchcock Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... Bronx, NY (PRWEB) , ... August 01, 2015 , ... ... Torah scroll currently housed at their Bronx campus. The goal is to bring this ... once again be used in Jewish rituals and religious services. , Scroll No. ...
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, Symantec released a ... to have been behind the attack on Anthem Inc. which resulted in one of ... watering hole attacks and spear phishing campaigns. , For Joe Caruso, founder ...
(Date:8/1/2015)... CT (PRWEB) , ... August 01, 2015 , ... On March 19, 2015 Phil Valentine ... mile trek of the Appalachian Trail by stepping off Springer Mountain and heading ... , On July 26th Phil reached Connecticut and was greeted by friends and family. ...
(Date:7/31/2015)... ... ... The Honor Society of Nursing, Sigma Theta Tau International (STTI) convened a regional ... 2015 in San Juan, Puerto Rico. Key nurse leaders from Central and Latin America(1) ... and Allied Health Personnel Development, Unit of Human Resources for Health, Department of Health ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... industry players to know in predictive health analytics , Jvion continues to ... The firm creates predictive software that targets patient and population level illness to ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2
... ... Wilson, Williams and West in regards to losses of IQ and Emotional Intelligence. Take EI ... ... of viewers Joe Wilson shouts "you lie, to the president, Serena Williams calls out line ...
... ... award for second year, based on superior academic performance and record of community service. Born ... in Southern California. , ... Angeles, CA (PRWEB) September 28, 2009 -- The David Geffen School of Medicine at UCLA ...
... , ... HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group are pleased to ... to serve as a resource for human capital thought leadership in the healthcare workplace ... ...
... ... Aging Services Access Point (ASAP) with main offices in Brockton has launched a Supportive ... live longer in the community and preventing premature institutionalization. , ... Plymouth County and Avon, Easton and Stoughton, ...
... more likely to die than patients with higher incomes. That ... to be published in the December 1, 2009 issue of ... Society. The study,s findings indicate that poor prostate cancer patients ... the previous studies on socioeconomic status (SES) and prostate cancer ...
... 2009) - Antibiotic resistance has been a significant problem for ... despite the need for new treatment options, there have been ... 40 years. Now a promising discovery by McMaster University ... interventions for resistant infections. Eric Brown, a professor and ...
Cached Medicine News:Health News:Outbursts: Where did Their IQ points Go and What were They Thinking? 2Health News:Outbursts: Where did Their IQ points Go and What were They Thinking? 3Health News:Outbursts: Where did Their IQ points Go and What were They Thinking? 4Health News:Winnick Family Scholarship Awarded to Ramona Davoudpour at UCLA School of Medicine 2Health News:Winnick Family Scholarship Awarded to Ramona Davoudpour at UCLA School of Medicine 3Health News:Winnick Family Scholarship Awarded to Ramona Davoudpour at UCLA School of Medicine 4Health News:Ascension Health, HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group announce the formation of The Healthcare Consortium 2Health News:Ascension Health, HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group announce the formation of The Healthcare Consortium 3Health News:Ascension Health, HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group announce the formation of The Healthcare Consortium 4Health News:Old Colony Elder Services Launches Supportive Housing Program in Plymouth 2Health News:Old Colony Elder Services Launches Supportive Housing Program in Plymouth 3Health News:Swiss study finds income affects prostate cancer patients' survival 2Health News:McMaster researchers discover a new antibacterial lead 2
(Date:7/31/2015)... 31, 2015  Xcelience, a contract development and ... made a structured cash investment in Powdersize, a ... milling, micronization and powder size classification within the ... business while simultaneously adding a complete set of ... capabilities. "As we continue to ...
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, asthma ... of Yujiro S. Hata to its board ... in business and corporate development is a tremendous asset ... president and chief executive officer of Xencor. "Xencor faces ...
(Date:7/30/2015)... SAN DIEGO , July 30, 2015 ... announced it has signed a definitive agreement ... provider of non-invasive ventilation and sleep-disordered breathing ... strong clinical, innovation and market reputation in China, combined with ResMed,s global leadership ... of people in China ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... LOS ANGELES, May 16, 2012  NeuroSigma, Inc., a ... its majority-owned subsidiary, NSVascular, Inc. (NSV), acquired a ... the fabrication of Thin-Film Nitinol (TFN) from TiNi ... "Three Dimensional Thin Film Devices and Methods of ...
... 2012  Rigel Pharmaceuticals, Inc., (Nasdaq: RIGL ) ... innovative, comprehensive treatment alternatives for patients with asthma. One ... be entering a Phase 2 clinical study later this ... R256, an inhaled IL13 signaling/JAK inhibitor, is potentially useful ...
Cached Medicine Technology:NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio 2NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio 3Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 2Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 3Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 4
... Contrast Sensitivity is Recognized as a ... Loss Caused by Early Eye Disease. ... in x 7 in (12.7cm x ... on a Refractor,Distance Test F.A.C.T. ...
Vision Testing for Infants and Non-Verbal Patients,Using Preferential Looking....
Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis...
Adult: Letter Acuity, Astigmatic Clock, Binocular Balance, Supression, Fixation Disparity, Stereopsis...
Medicine Products: